Acne DHEA versus tibolone · Women in the peri‐ or postmenopausal phase
It is very uncertain whether DHEA changes acne DHEA versus tibolone compared with HT (very low certainty).
1 finding from 1 review
Acne DHEA versus ET + P · Women in the peri‐ or postmenopausal phase
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Side effects (androgenic overall combined with acne) number of events · Women in the peri‐ or postmenopausal phase
DHEA probably leads to higher side effects (androgenic overall combined with acne) number of events compared with control (placebo or no treatment) (moderate certainty).
1 finding from 1 review
Side effects ‐ androgenic side effects number of events · Women in the peri‐ or postmenopausal phase
DHEA may leads to higher side effects ‐ androgenic side effects number of events compared with control (placebo or no treatment) (low certainty).
1 finding from 1 review
Adverse effects: acne · Women in the peri‐ or postmenopausal phase
DHEA showed no clear difference in side effects ‐ acne number of events compared with control (placebo or no treatment) (moderate certainty).
1 finding from 1 review
QoL · Women in the peri‐ or postmenopausal phase
2 findings from 1 review
Side effects: acne ‐ skin application · Women in the peri‐ or postmenopausal phase
It is very uncertain whether oral DHEA changes side effects: acne ‐ skin application compared with control subgrouped by differing routes of administration (very low certainty).
1 finding from 1 review
Side effects: acne ‐ oral administration · Women in the peri‐ or postmenopausal phase
It is very uncertain whether oral DHEA changes side effects: acne ‐ oral administration compared with control subgrouped by differing routes of administration (very low certainty).
1 finding from 1 review
QoL, general wellbeing DHEA versus ET · Women in the peri‐ or postmenopausal phase
1 finding from 1 review
Postoperative ileus · Women who had major abdominal gynaecologic surgery
Early oral feeding showed no clear difference in postoperative ileus compared with delayed oral feeding (moderate certainty).
1 finding from 1 review
Maternal nausea and/or vomiting · Women who had major abdominal gynaecologic surgery
Early oral feeding showed no clear difference in nausea or vomiting or both compared with delayed oral feeding (moderate certainty).
1 finding from 1 review
Time to bowel sounds [days] · Women who had major abdominal gynaecologic surgery
1 finding from 1 review
Time from completion of operation to first flatus (hours) · Women who had major abdominal gynaecologic surgery
1 finding from 1 review
Postoperative time to solid diets (days) · Women who had major abdominal gynaecologic surgery
1 finding from 1 review
Time to first BM (№ women with 1st BM on day 2 after delivery) · Women who had major abdominal gynaecologic surgery
1 finding from 1 review
Length of hospital stay · Women who had major abdominal gynaecologic surgery
1 finding from 1 review
Postoperative pain at 6 hours VAS from 0 to 10 · women with uterine fibroids
1 finding from 1 review
Postoperative pain at 24 hours VAS from 0 to 10 · women with uterine fibroids
1 finding from 1 review
Postoperative pain at 48 hours VAS from 0 to 10 · women with uterine fibroids
1 finding from 1 review
Perioperative in‐hospital adverse events; unscheduled return to theatre · women with uterine fibroids
Laparoscopic myomectomy showed no clear difference in perioperative in‐hospital adverse events; unscheduled return to… compared with open myomectomy (all types) (low certainty).
1 finding from 1 review